BINEX Co., Ltd. (053030.KQ)
KRW 17490.0
(-3.95%)
KRW 17490.0
(-3.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 56.65 Billion KRW | -19.31% |
| 2022 | 70.21 Billion KRW | 18.21% |
| 2021 | 59.39 Billion KRW | -4.73% |
| 2020 | 62.34 Billion KRW | 11.28% |
| 2019 | 56.02 Billion KRW | 17.77% |
| 2018 | 47.57 Billion KRW | 71.95% |
| 2017 | 27.66 Billion KRW | -2.29% |
| 2016 | 28.31 Billion KRW | -12.32% |
| 2015 | 32.29 Billion KRW | 0.0% |
| 2013 | 18.24 Billion KRW | -26.58% |
| 2012 | 24.85 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.26 Billion KRW | -76.78% |
| 2024 Q2 | 5.15 Billion KRW | 136.27% |
| 2023 Q1 | 23.17 Billion KRW | 37.1% |
| 2023 Q2 | 14.93 Billion KRW | -35.55% |
| 2023 FY | 56.65 Billion KRW | -19.31% |
| 2023 Q3 | 8.8 Billion KRW | -41.06% |
| 2023 Q4 | 9.74 Billion KRW | 10.72% |
| 2022 Q4 | 16.9 Billion KRW | -7.94% |
| 2022 Q3 | 18.35 Billion KRW | -11.29% |
| 2022 Q2 | 20.69 Billion KRW | 45.63% |
| 2022 FY | 70.21 Billion KRW | 18.21% |
| 2022 Q1 | 14.21 Billion KRW | -22.56% |
| 2021 Q1 | 15.67 Billion KRW | -5.97% |
| 2021 Q2 | 11.31 Billion KRW | -27.79% |
| 2021 Q3 | 14.05 Billion KRW | 24.23% |
| 2021 Q4 | 18.35 Billion KRW | 30.54% |
| 2021 FY | 59.39 Billion KRW | -4.73% |
| 2020 Q2 | 16.03 Billion KRW | 17.38% |
| 2020 Q3 | 16.49 Billion KRW | 2.88% |
| 2020 Q4 | 16.66 Billion KRW | 1.06% |
| 2020 FY | 62.34 Billion KRW | 11.28% |
| 2020 Q1 | 13.65 Billion KRW | -9.2% |
| 2019 Q4 | 15.04 Billion KRW | 11.22% |
| 2019 Q2 | 15.41 Billion KRW | 21.33% |
| 2019 Q1 | 12.7 Billion KRW | -14.43% |
| 2019 FY | 56.02 Billion KRW | 17.77% |
| 2019 Q3 | 13.52 Billion KRW | -12.29% |
| 2018 Q2 | 10.86 Billion KRW | 19.85% |
| 2018 FY | 47.57 Billion KRW | 71.95% |
| 2018 Q4 | 14.85 Billion KRW | 11.4% |
| 2018 Q3 | 13.33 Billion KRW | 22.72% |
| 2018 Q1 | 9.06 Billion KRW | 19.05% |
| 2017 FY | 27.66 Billion KRW | -2.29% |
| 2017 Q3 | 6.53 Billion KRW | 31.06% |
| 2017 Q2 | 4.98 Billion KRW | -45.41% |
| 2017 Q4 | 7.61 Billion KRW | 16.44% |
| 2017 Q1 | 9.13 Billion KRW | 116.18% |
| 2016 Q2 | 7.94 Billion KRW | -9.84% |
| 2016 Q3 | 7.96 Billion KRW | 0.22% |
| 2016 Q4 | 4.22 Billion KRW | -46.91% |
| 2016 FY | 28.31 Billion KRW | -12.32% |
| 2016 Q1 | 8.81 Billion KRW | 31.68% |
| 2015 Q1 | 6.79 Billion KRW | 0.0% |
| 2015 Q4 | 6.69 Billion KRW | -24.85% |
| 2015 FY | 32.29 Billion KRW | 0.0% |
| 2015 Q3 | 8.9 Billion KRW | 20.61% |
| 2015 Q2 | 7.38 Billion KRW | 8.57% |
| 2014 Q1 | 6.02 Billion KRW | 157.99% |
| 2014 Q2 | 7.6 Billion KRW | 26.14% |
| 2014 Q3 | 5.58 Billion KRW | -26.49% |
| 2013 Q4 | 2.33 Billion KRW | -59.16% |
| 2013 Q1 | 3.94 Billion KRW | -33.04% |
| 2013 Q3 | 5.71 Billion KRW | -7.4% |
| 2013 Q2 | 6.17 Billion KRW | 56.57% |
| 2013 FY | 18.24 Billion KRW | -26.58% |
| 2012 Q3 | 4.89 Billion KRW | 0.0% |
| 2012 Q4 | 5.89 Billion KRW | 20.3% |
| 2012 FY | 24.85 Billion KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| HLB Co., Ltd. | -6.01 Billion KRW | 1042.296% |
| iNtRON Biotechnology, Inc. | 4.56 Billion KRW | -1142.205% |
| Bioneer Corporation | 199.25 Billion KRW | 71.566% |
| Anterogen.Co.,Ltd. | 2.21 Billion KRW | -2459.607% |
| MEDIPOST Co., Ltd. | 40.18 Billion KRW | -40.989% |
| CrystalGenomics, Inc. | 1.45 Billion KRW | -3788.48% |
| Helixmith Co., Ltd | 2.12 Billion KRW | -2570.091% |
| Chabiotech Co.,Ltd. | 255.19 Billion KRW | 77.799% |
| Medy-Tox Inc. | 128.16 Billion KRW | 55.794% |
| Peptron, Inc. | 1.14 Billion KRW | -4867.245% |
| Amicogen, Inc. | 51.51 Billion KRW | -9.983% |
| Genexine, Inc. | 387.48 Million KRW | -14521.31% |
| HLB Therapeutics Co.,Ltd. | 6.69 Billion KRW | -746.328% |
| LegoChem Biosciences, Inc. | 17.79 Billion KRW | -218.337% |
| ALTEOGEN Inc. | 31.19 Billion KRW | -81.596% |
| PharmaResearch Co., Ltd. | 182.25 Billion KRW | 68.914% |
| SillaJen, Inc. | 1.45 Billion KRW | -3789.18% |
| JETEMA, Co., Ltd. | 26.58 Billion KRW | -113.134% |
| OliX Pharmaceuticals,Inc | 14.42 Billion KRW | -292.831% |
| Genomictree Inc. | -1.03 Billion KRW | 5555.007% |
| MedPacto, Inc. | -1.83 Billion KRW | 3191.419% |
| D&D Pharmatech | 18.67 Billion KRW | -203.342% |
| EASY BIO,Inc. | 50.88 Billion KRW | -11.338% |
| GI Innovation, Inc. | 1.98 Billion KRW | -2747.828% |